Swollen axillary lymph nodes associated with the COVID-19 vaccine last longer than initially reported
- Subversive discovery: Can lymph nodes promote the success of cancer immunotherapy?
- Major Discovery: Cancer cell PD-L1 does not inhibit T cell toxicity
- The new coronavirus may kill cancer cells and achieve a permanent cure!
- Why did the Alzheimer’s drug candidate BACE1 inhibitor fail?
- LRTI Death: Research spanning 80 years confirms for the first time
- The decline of the global antibiotic market is threatening the development of new drugs
Swollen axillary lymph nodes associated with the COVID-19 vaccine last longer than initially reported
- More than 1 million Chinese died after China quit “Zero-COVID policy”?
- Why is Vinyl chloride listed as a Class A “known human carcinogen” ?
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
Swollen axillary lymph nodes associated with the COVID-19 vaccine last longer than initially reported.
The duration of axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination was longer than reported in previous initial vaccine clinical trials.
A new study published in ARRS’ American Journal of Roentgenology (AJR) shows that axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination lasts longer than reported in initial vaccine clinical trials .
“The extended resolution time supports a follow-up interval of at least 12 weeks for suspected vaccine-related lymphadenopathy and avoidance of post-vaccination post-vaccination mammograms,” wrote Michele B. Drotman, the study’s corresponding author of the paper.
Dotman and a team from Weill Cornell Medicine extracted health record data from 111 patients (average age 52 years) who developed unilateral axillary lymphadenopathy on the same side after vaccination with Pfizer or Moderna COVID-19.
Follow-up ultrasound within 4-12 weeks – breast ultrasound within the previous 8 weeks (January 1-October 1, 2021).
In this single-center study, ipsilateral axillary lymphadenopathy following COVID-19 mRNA vaccination resolved on average 97 days after breast imaging and 127 days after first dose.
Moderna (but not Pfizer) vaccinations had longer resolution times, received a second dose after onset, and had thicker cortical thickness at onset.
“The presence of subclinical lymphadenopathy and the longer resolution of lymphadenopathy should reassure radiologists and patients when lymph nodes suspected of being vaccine-related persist across multiple visits,” the authors of the article noted.
Swollen axillary lymph nodes associated with the COVID-19 vaccine last longer than initially reported
(source:internet, reference only)
Disclaimer of medicaltrend.org
